MRI Protocol Explorer
Current (2025–2026) protocol recommendations with representative parameters. Pick a category, set your scanner vendor to translate sequence names, open a body part, and tick sequences off as you scan.
Overview
Cross-cutting 2025–2026 developments that shape every protocol below.
High-Yield Pearls — cross-cutting
- MR safety (ACR 2024): a “full stop” final safety check precedes every scan, routine or emergency; new MR risk-assessment appendix for implants; strict Zone III/IV discipline.
- Contrast (ACR 2025): macrocyclic / Group II agents are the lowest-risk GBCAs; weight-based dosing; group-based renal screening rather than a blanket eGFR cut-off.
- Contrast-sparing is the trend: biparametric prostate, abbreviated liver/breast, and non-contrast MRA increasingly replace routine gadolinium.
- Acceleration & AI: deep-learning reconstruction with parallel imaging cuts scan time substantially — validate image quality locally before clinical adoption.
MR safety (ACR)
Contrast media (ACR 2025)
Acceleration & AI reconstruction
Neuro & spine
Brain and spine. Where a pathology needs a distinct protocol it is listed in full — set your vendor above to translate sequence names.
High-Yield Pearls — neuro & spine
- Routine brain = T1, T2, FLAIR, DWI, SWI (± post-Gd 3D T1). DWI is the non-negotiable sequence — stroke, abscess, CJD, cellularity.
- Stroke: DWI + FLAIR + SWI/GRE + MRA in minutes. A DWI-positive / FLAIR-negative mismatch implies onset <4.5 h → thrombolysis candidate in wake-up/unknown-onset stroke (WAKE-UP).
- MS (2024 McDonald): 3D FLAIR is the primary detection sequence; central vein sign and paramagnetic rim lesions (optimally 3T SWI) add specificity; gadolinium is increasingly optional.
- Epilepsy (HARNESS-MRI): 1 mm-isotropic 3D T1 + 3D FLAIR plus a high-resolution coronal T2 ⊥ the hippocampal long axis.
- Brain tumour (BTIP): parameter-matched pre/post 3D T1 is what enables reproducible RANO response assessment.
- Spine: sagittal T1 + T2 ± STIR; add fat-sat post-Gd for infection/tumour/post-op; screen the whole spine for cord compression or drop metastases.
Routine brain0/6
First-line brain screen. Add post-contrast T1 for tumour, infection, or active MS.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| or 3D T1 | Ax | 500–700 | 8–15 | – | 5 / 1 | 220–240 | 320×256 | Anatomy | |
| Ax | 3500–5000 | 90–110 | – | 5 / 1 | 220 | 384–512 | – | ||
| Ax | 8000–9000 | 90–120 | 2400–2500 | 5 / 1 | 220 | 256 | TI↑ at 3T | ||
| Ax | 3000–5000 | min | – | 4–5 | 230 | 128–160 | b0/1000; ADC | ||
| Ax | 27 | 20–40 | – | 2–3 | 220 | 256–320 | minIP; blood/mineral | ||
| post-Gd if indicated | Sag 3D | 1900–2300 | 2–4 | ~900 | 1 iso | 240 | 256 | Volumetry |
ACR-ASNR-SPR practice pattern.7
Acute stroke0/5
Speed-first; DWI+FLAIR+SWI+MRA in minutes. Add neck CE-MRA/TOF for carotid/vertebral. Extended wake-up windows (>4.5–9 h) are evolving, not yet uniform guideline.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Ax | 3000–4000 | min | – | 4–5 | 230 | 128–160 | b0/1000; ADC — infarct core | ||
| Ax | 8000–9000 | 100–120 | 2400 | 5 | 230 | 256 | DWI+/FLAIR− mismatch → likely <4.5 h | ||
| or GRE | Ax | 27 | 20–40 | – | 3 | 230 | 256 | Haemorrhage, susceptibility vessel sign | |
| intracranial | Ax 3D | 20–25 | 3–7 | – | 0.6–1 | 200 | 320 | Circle of Willis; large-vessel occlusion | |
| optional | Ax | 1500 | 30–45 | – | 5 | 230 | 128 | Penumbra (PWI) |
AHA/ASA; ESO; DWI–FLAIR mismatch; extended windows.8,9,10,11
Multiple sclerosis0/5
2024 McDonald + 2024 MAGNIMS–CMSC–NAIMS. ≤3 mm/no gap; consistent repositioning for follow-up.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Sag 3D | 5000–8000 | ~390 eff | 1800–2200 | 1 iso | 250 | 256 | Primary lesion detection | ||
| pre ± post-Gd | Sag 3D | 2000 | 2–4 | ~900 | 1 iso | 250 | 256 | Single dose, ~10 min delay | |
| Ax | 4000 | 90 | – | 3 | 230 | 320 | Posterior fossa | ||
| Ax | 3000 | min | – | 4 | 230 | 160 | Exclude mimics | ||
| Ax | 27 | 20–40 | – | 2–3 | 220 | 320 | Central vein sign / rim lesions (optimally 3T) |
EpilepsyHARNESS0/4
ILAE HARNESS-MRI. Correct head tilt/rotation on the localiser before the coronal T2.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Sag 3D | 2000 | 2–4 | ~900 | 1 iso | 256 | 256 | Morphology / cortex | ||
| Sag 3D | 5000–8000 | ~390 eff | 1800–2200 | 1 iso | 250 | 256 | FCD / gliosis | ||
| high-res | Cor obl | 5000–9000 | 90–110 | – | 2 / 0 | 180–200 | 512 | ⟂ hippocampal long axis; ~0.4 mm | |
| if lesion | Ax | 27 | 20–40 | – | 2–3 | 220 | 320 | Add post-Gd T1 if tumour/vascular |
ILAE HARNESS-MRI.15
Brain tumourBTIP0/6
Standardised BTIP; identical pre/post parameters enable RANO response assessment.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| pre | Sag 3D | 2100 | min | 400–450 | 1 iso | 256 | 256 | Parameter-matched | |
| Ax | 4000 | 100 | – | ≤4 / 0 | 240 | 384 | – | ||
| Ax | 8000 | 120 | 2400 | ≤4 / 0 | 240 | 256 | Pre-contrast | ||
| Ax | 4000 | min | – | 4 | 240 | 160 | b0/1000; ADC (cellularity) | ||
| post-Gd | Sag 3D | 2100 | min | 400–450 | 1 iso | 256 | 256 | Identical to pre | |
| advanced, optional | Ax | 1500 | 30–45 | – | 5 | 240 | 128 | Perfusion (rCBV) ± spectroscopy |
Dementia / neurodegeneration0/5
Reformat coronal-oblique T1 through hippocampi for MTA (Scheltens); optional volumetry.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| coronal-oblique reformat | Sag 3D | 2000 | 2–4 | ~900 | 1 iso | 240 | 256 | MTA ⟂ hippocampus | |
| Ax | 8000 | 120 | 2400 | 5 | 230 | 256 | Vascular burden | ||
| Ax | 4000 | 100 | – | 5 | 230 | 320 | – | ||
| Ax | 27 | 20–40 | – | 2–3 | 220 | 320 | Microbleeds / CAA | ||
| Ax | 3000 | min | – | 4 | 230 | 160 | Exclude CJD/acute |
Radiology Assistant; ACR appropriateness.18
Pituitary / sella0/4
Thin-section sella; dynamic post-contrast for microadenoma. Representative standard technique.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| pre | Sag & Cor | 400–600 | 10–15 | – | 2–3 / 0 | 160–180 | 320–512 | Small FOV, thin | |
| Cor | 3000 | 90 | – | 2–3 | 160–180 | 384 | Chiasm, cysts | ||
| dynamic post-Gd | Cor | min | min | – | 2–3 | 160–180 | 256 | ~6 phases — microadenoma | |
| post-Gd | Sag & Cor | 400–600 | 10–15 | – | 2–3 | 160–180 | 320 | Delayed |
IAM / CPA (hearing loss)0/4
Thin 3D heavy-T2 (CISS/FIESTA-C/DRIVE) + post-Gd T1 for CN VII/VIII. Representative standard technique.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Ax 3D | 6–10 | 3–5 | – | 0.5–0.6 iso | 150–160 | 320 | Membranous labyrinth, CN VII/VIII | ||
| pre | Ax | 500 | 12 | – | 3 | 180 | 320 | IAM fat | |
| post-Gd fat-sat | Ax & Cor | 500 | 12 | – | 3 | 180 | 320 | Vestibular schwannoma | |
| Ax | 4000 | 90 | – | 3–4 | 200 | 320 | Posterior fossa |
Cervical (routine)0/4
Add fat-sat post-Gd T1 for infection/tumour/post-op.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Sag | 500–700 | 10–15 | – | 3 / 0.3 | 240–280 | 384 | Marrow, alignment | ||
| Sag | 3000–4000 | 100–120 | – | 3 / 0.3 | 240–280 | 384 | Cord, discs | ||
| Sag | 3000–4000 | 40 | 150–170 | 3 | 240–280 | 320 | Oedema / trauma | ||
| or Ax T2 FSE | Ax | 600–800 | 15–20 | – | 3–4 / 1 | 160–180 | 256–320 | Foramina, cord |
Representative routine protocol.19
Thoracic (routine)0/4
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Sag | 500–700 | 10–15 | – | 3–4 / 0.5 | 320–400 | 384 | Wide coverage — count levels | ||
| Sag | 3000–4000 | 100–120 | – | 3–4 | 320–400 | 384 | Cord | ||
| Sag | 3500 | 40 | 150–170 | 3–4 | 320–400 | 320 | Oedema | ||
| Ax | 3500 | 100 | – | 4 | 180–200 | 256 | Through ROI |
Representative routine protocol.19
Lumbar (routine)0/5
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Sag | 500–700 | 10–15 | – | 3–4 / 1 | 280–320 | 384 | Marrow, alignment | ||
| Sag | 3000–4000 | 100–120 | – | 3–4 / 1 | 280–320 | 384 | Discs, canal | ||
| optional | Sag | 3500 | 40 | 150–170 | 3–4 | 280–320 | 320 | Oedema / infection | |
| Ax | 3500–4500 | 100 | – | 3–4 / 1 | 180–200 | 320 | Angled through discs | ||
| optional | Ax | 600 | 12 | – | 3–4 | 180–200 | 320 | Foraminal fat |
Representative routine protocol.19
MS cord0/4
MAGNIMS cord protocol; slice ≤3 mm.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Sag | 3500 | 100–120 | – | 3 | 260–280 | 384 | Cord lesions | ||
| or STIR | Sag | 3000 | 30 | – | 3 | 260–280 | 384 | ≥2 of 3 sagittal contrasts | |
| Ax | 3500 | 100 | – | 3 | 160–180 | 256 | Full cord coverage — confirmation | ||
| post-Gd if active | Sag & Ax | 600 | 12 | – | 3 | 260 | 320 | Active lesions |
MAGNIMS–CMSC–NAIMS.14
Infection / discitis0/4
Fat-sat post-Gd essential for epidural/paraspinal collection.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Sag | 500–700 | 12 | – | 3–4 | 280–320 | 384 | Marrow, endplates | ||
| or T2 fat-sat | Sag | 3500 | 40 | 150–170 | 3–4 | 280–320 | 320 | Discitis/osteomyelitis | |
| Ax | 3500 | 100 | – | 4 | 180–200 | 256 | Canal, paraspinal | ||
| post-Gd fat-sat | Sag & Ax | 600 | 12 | – | 3–4 | 280 | 320 | Abscess / epidural phlegmon |
Representative protocol.19
Cord compression / whole-spine0/4
Acute cord compression or cauda equina — large-FOV whole-spine screen.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Sag | 3500 | 100 | – | 3–4 | 400+ (2 stations) | 384 | Whole spine — compression / drop mets | ||
| Sag | 3500 | 40 | 150–170 | 3–4 | 400+ | 320 | Marrow lesions | ||
| Ax | 3500 | 100 | – | 4 | 180–200 | 256 | Targeted level | ||
| ± post-Gd | Sag | 600 | 12 | – | 3–4 | 400+ | 320 | Leptomeningeal / mets |
Musculoskeletal
Each joint lists its routine protocol plus pathology-specific/arthrography protocols in full. ACR figures are accreditation ceilings, not optimal technique.
High-Yield Pearls — musculoskeletal
- Fat-sat fluid-sensitive (PD/T2 or STIR) on ≥1 plane finds marrow & soft-tissue oedema; T1 maps marrow and anatomy. ACR figures are accreditation ceilings, not optimal technique.
- MR arthrography: dilute gadolinium to ~2 mmol/L (~1:200) intra-articular; the ABER view is key for the anteroinferior labrum / HAGL in shoulder instability.
- Positioning drives the diagnosis: oblique-coronal ∥ supraspinatus (cuff), oblique-axial along the femoral neck (cam/alpha angle), radial reformats for the acetabular labrum, short-axis ⊥ metatarsals for Morton neuroma.
- Metal (MARS): high receiver bandwidth, short TE, FSE not GRE, and STIR not spectral fat-sat; add SEMAC / MAVRIC-SL 3D multispectral for severe hardware artifact.
- Whole-body (MY-RADS): axial DWI (b 50 & ~900) + Dixon T1; overall study quality is usually limited by DWI quality.
Routine (internal derangement)0/5
Fat-sat on ≥1 plane. ACR max 4 mm / 0.6 mm².
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Sag | 2500–3500 | 30–40 | – | 3–3.5 / 0.3 | 140–160 | 320–384 | Menisci; ~0.4 mm | ||
| fat-sat | Sag | 3000–4000 | 40–60 | – | 3–3.5 | 140–160 | 320 | Cartilage, cruciates | |
| fat-sat | Cor | 3000 | 40 | – | 3 | 140–160 | 320 | Collaterals, menisci | |
| fat-sat | Ax | 3000 | 60 | – | 3–4 | 140–160 | 288 | Patellofemoral cartilage | |
| or Dixon | Cor | 500–700 | 12 | – | 3–4 | 140–160 | 320 | Marrow (non-FS) |
Cartilage / quantitative0/3
Quantitative T2/T1rho used in research and early OA; not yet routine clinically.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| fat-sat 3D | Sag 3D | 1200 | 30 | – | 0.5–0.7 iso | 150 | 320 | Morphological cartilage; reformats | |
| Sag | 1500 | multi-echo | – | 3 | 140 | 320 | Collagen/water; T1rho adjunct | ||
| fat-sat | Sag/Cor | 3000 | 40 | – | 3 | 140–160 | 320 | Routine base |
AJR 2024.31
MR arthrography (post-op)0/2
Post-op meniscal re-tear / cartilage. Macrocyclic Group II GBCA.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| fat-sat | Sag/Cor/Ax | 500–700 | min | – | 3 | 140–160 | 320 | Dilute Gd ~2 mmol/L intra-articular | |
| fat-sat | one plane | 3000 | 60 | – | 3 | 140–160 | 288 | Loose bodies, oedema |
Gd dilution vs field.27
Routine (cuff / impingement)0/4
ACR max 4 mm / 0.8 mm².
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Ax | 2500–3000 | 30 | – | 3–4 / 0.3 | 140–160 | 320 | Labrum, biceps | ||
| fat-sat / STIR | Obl-Cor | 3500 | 50–60 | – | 3–4 | 140–160 | 320 | ∥ supraspinatus — cuff | |
| fat-sat | Obl-Sag | 3000 | 40 | – | 3–4 | 140–160 | 288 | Cuff muscles, Goutallier | |
| Obl-Cor | 500–700 | 12 | – | 3–4 | 140–160 | 320 | Marrow, fatty atrophy |
ACR MSK.33
MR arthrography (instability)0/5
Instability work-up; ABER view essential.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| fat-sat | Ax | 500–700 | min | – | 3 | 140–160 | 320 | Dilute Gd ~2 mmol/L; Bankart/SLAP | |
| fat-sat | Obl-Cor | 500–700 | min | – | 3 | 140–160 | 320 | Superior labrum | |
| fat-sat | Obl-Sag | 500–700 | min | – | 3 | 140–160 | 320 | – | |
| fat-sat, ABER | ABER obl-ax | 500–700 | min | – | 3 | 140–160 | 320 | Anteroinferior labrum, PASTA, HAGL | |
| fat-sat | one plane | 3000 | 60 | – | 3 | 140–160 | 288 | Cuff / oedema |
Gd dilution; ABER.27
Routine / AVN0/4
AVN, marrow, referred pain.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| or T2 fat-sat | Cor (pelvis) | 3500 | 40 | 150–170 | 4–5 | 340–380 | 320 | Both hips, marrow, AVN screen | |
| Cor (pelvis) | 500–700 | 12 | – | 4–5 | 340–380 | 384 | Marrow, AVN | ||
| Ax (small-FOV) | 2500 | 30 | – | 3–4 | 160–180 | 320 | Symptomatic hip | ||
| fat-sat | Cor (small-FOV) | 3000 | 60 | – | 3–4 | 160–180 | 288 | Labrum, effusion |
FAI / labral0/4
Radial reformats around the femoral neck are key.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Obl-Ax | 2500 | 30 | – | 2–3 | 160 | 320 | Along femoral neck — alpha angle (cam) | ||
| radial | Radial | 2500 | 30 | – | 3 | 160 | 320 | Acetabular clock-face labrum | |
| fat-sat | Cor/Ax | 3000 | 60 | – | 3 | 160–180 | 288 | Chondrolabral | |
| fat-sat, arthrography (optional) | 3 planes | 500–700 | min | – | 3 | 160 | 320 | Dilute Gd ~2 mmol/L distension |
ACR MSK.33
Routine0/4
Smallest FOV in MSK. ACR max 3 mm / 0.3 mm².
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Cor-obl | 500–600 | min | – | 2–3 / 0.2 | 80–100 | 256–320 | SL ligament, marrow; ~0.3 mm | ||
| fat-sat | Cor-obl | 2500–3000 | 40 | – | 2–3 | 80–100 | 256–320 | TFCC, ligaments | |
| fat-sat | Ax | 2500 | 40 | – | 3 | 80–100 | 256 | Tendons, carpal tunnel | |
| fat-sat | Cor | 3000 | 60 | – | 2–3 | 80–100 | 256 | Oedema |
ACR MSK.33
Arthrography (TFCC / instability)0/3
Three-compartment injection for intrinsic ligament / TFCC tears.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| fat-sat | Cor | 500–600 | min | – | 2 | 80–100 | 320 | Dilute Gd; TFCC / ligaments | |
| fat-sat | Ax | 500–600 | min | – | 2–3 | 80–100 | 256 | – | |
| or 3D GRE | Cor 3D | 1000 | min | – | 0.4 iso | 90 | 320 | Intrinsic ligaments |
Ankle (routine)0/4
Dixon efficient; oblique planes for ATFL. Ankle has no dedicated ACR table.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Sag | 500–700 | 12 | – | 3 / 0.3 | 140–160 | 320 | Marrow, tendons | ||
| fat-sat | Ax | 3000 | 40 | – | 3 | 140–160 | 288 | Tendons, ligaments (ATFL obl) | |
| fat-sat | Sag | 3000 | 40 | – | 3 | 140–160 | 288 | Achilles, plantar fascia | |
| fat-sat | Cor | 3000 | 60 | – | 3 | 140–160 | 288 | Osteochondral, ligaments |
Forefoot (Morton / plantar plate)0/4
Planes prescribed relative to the metatarsals. ACR forefoot 3 mm / 0.4 mm².
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| fat-sat, short-axis | Short-ax | 3000 | 60 | – | 3 / 0.3 | 100–120 | 256 | ⟂ metatarsals — Morton, plantar plate | |
| short-axis | Short-ax | 500 | 12 | – | 3 | 100–120 | 256 | Neuroma (T1-iso), marrow | |
| fat-sat, long-axis | Long-ax | 3000 | 40 | – | 3 | 100–120 | 256 | Plantar plate | |
| fat-sat | Sag | 3000 | 60 | – | 3 | 100–120 | 256 | – |
ACR MSK.33
Fat suppression, 2D vs 3D & acceleration
- Spectral fat-sat = best SNR but fails off-isocentre/near metal; STIR = most uniform; Dixon (increasingly default) gives water/fat/in/opposed in one acquisition.23
- 2D FSE is the workhorse; 3D isotropic (SPACE/CUBE/VISTA/MVOX) gives sub-mm reformats — but ACR still requires each plane separately acquired.24,25
- DL-accelerated / abbreviated joint protocols validated with preserved accuracy.28
Metal artifact reduction (MARS)0/3
Optimise first: high bandwidth, thin slices + large matrix, short TE, FSE/TSE + STIR (avoid GRE near metal).
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Cor/Ax | 4000 | 30 | 150 | 3–4 | per joint | 320 | High BW 400–540 Hz/px; STIR not spectral FS | ||
| VAT / SEMAC | per joint | 600 | min | – | 3–4 | per joint | 320 | View-angle tilt; SEMAC-CS through-plane | |
| SEMAC / MAVRIC-SL | per joint | 4000 | 80 | – | 3–4 | per joint | 256 | 3D multispectral |
Whole-body (MY-RADS / MET-RADS-P)0/3
Myeloma / metastatic prostate; overall quality is usually limited by DWI quality.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| multi-station | Ax | long | min | STIR | 5–6 | multi | 128 | b50–100 & 800–900; ADC | |
| T1, multi-station | Ax | min | dual-echo | – | 5–6 | multi | 256 | Water/fat/in/opposed | |
| and T2 FSE/STIR | Sag | 600 | 12 | – | 4 | whole spine | 384 | Whole spine |
MY-RADS.32
- Smaller FOV, child-sized coils, higher relative resolution; shorter protocols reduce sedation.34
- JIA: fluid-sensitive FS/STIR + T1; fat-sat T1 post-Gd within ~5–10 min for enhancing synovitis; DWI emerging as a non-contrast biomarker.35,36
- Normal physes / red marrow can mimic pathology — pair fluid-sensitive FS with a fat-sensitive (T1/Dixon) sequence.
Body & oncology
Structured systems (PI-RADS, LI-RADS, MY-RADS) specify acquisition and interpretation. Screening/surveillance uses biparametric or abbreviated, contrast-sparing protocols — listed separately in full.
High-Yield Pearls — body & oncology
- Structured systems define both acquisition and interpretation: PI-RADS v2.1 (prostate), LI-RADS (liver), VI-RADS (bladder), O-RADS (ovary), ccLS (renal), MY-RADS (whole-body).
- Prostate: mpMRI = T2 + DWI (high b ≥1400) + DCE (≤15 s temporal); biparametric screening (PRISM) drops contrast and the endorectal coil.
- Liver: extracellular agent for the dynamic study; gadoxetate adds a ~20-min hepatobiliary phase; abbreviated non-contrast (T2 + DWI) for HCC surveillance.
- Breast: image on days 7–14 of the cycle to lower background enhancement; Kuhl abbreviated (FAST, ~3 min) approaches full-protocol accuracy.
- Rectal (ESGAR): high-resolution oblique T2 ⊥ the tumour; DWI is integral to restaging (residual tumour vs fibrosis); no routine DCE.
- Chemical shift (in/opposed-phase): adrenal adenoma if signal-intensity index >16.5%; also detects microscopic fat in renal masses (ccLS).
- Obstetric/fetal & PAS: 1.5 T, no contrast, no sedation; single-shot T2 is the workhorse; placenta accreta uses the 7 SAR–ESUR features.
mpMRI (PI-RADS v2.1)0/4
3T preferred, 1.5T acceptable; endorectal coil optional.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Ax obl | 3000–5000 | 100–120 | – | 3 / 0 | 120–200 | 320–384 | + sag/cor; ~0.4–0.7 mm; zonal anatomy | ||
| Ax | 3000–5000 | min | – | 3–4 | 200–220 | 96–128 | b0-100, 800-1000 + high b≥1400 (acq/calc); ADC | ||
| DCE | Ax 3D | min | min | – | 3 | 200–220 | 192 | Temporal res ≤15 s; post-Gd | |
| Ax | 500–700 | 10 | – | 4–5 | 300–360 | 256 | Haemorrhage, nodes, bone |
PI-RADS v2.1.37
Screening bpMRI (PRISM)New0/2
Full diagnostic (extracellular agent)0/4
Multiphasic dynamic; chemical-shift for steatosis/iron.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| in/opposed-phase | Ax 3D | min | dual-echo | – | 3–4 | 360–420 | 256 | Chemical shift | |
| ± fat-sat | Ax/Cor | 1500–2500 | 80–100 | – | 5–6 | 360–420 | 320 | Lesion characterisation | |
| Ax | long | min | – | 5–6 | 360–420 | 128 | b0/50, 400–500, 800; ADC | ||
| dynamic post-Gd fat-sat | Ax 3D | min | min | – | 3 | 360–420 | 256 | Late arterial / PV / delayed |
Gadoxetate (hepatobiliary)0/5
Add hepatobiliary phase ~20 min post-injection.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| in/opposed-phase | Ax 3D | min | dual-echo | – | 3–4 | 360–420 | 256 | Chemical shift | |
| ± fat-sat | Ax | 1500–2500 | 80–100 | – | 5–6 | 360–420 | 320 | – | |
| Ax | long | min | – | 5–6 | 360–420 | 128 | b0/50, 400, 800; ADC | ||
| dynamic post-Gd | Ax 3D | min | min | – | 3 | 360–420 | 256 | Arterial / PV / transitional | |
| hepatobiliary phase | Ax 3D | min | min | – | 3 | 360–420 | 256 | ~20 min post-injection |
Abbreviated (non-contrast surveillance)0/2
Non-contrast HCC surveillance ~10 min.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| ± fat-sat | Ax | 1500 | 90 | – | 5–6 | 380 | 256 | Surveillance | |
| Ax | long | min | – | 5–6 | 380 | 128 | b0/500/800; ADC |
AMRI.43
Full dynamic0/4
Days 7–14 of cycle (premenopausal) to minimise background parenchymal enhancement.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| pre, fat-sat | Ax 3D | min | min | – | ≤1–1.5 | 320–360 | 384 | Bilateral high-res | |
| dynamic post ×4–5, fat-sat | Ax 3D | min | min | – | ≤1–1.5 | 320–360 | 384 | ≤60–90 s/phase; subtraction + MIP; kinetics | |
| Ax | 3000–4000 | 90 | – | 3–4 | 320–360 | 384 | Cysts, oedema | ||
| Ax | long | min | – | 4 | 320–360 | 128 | b0/800; SPAIR; adjunct |
Abbreviated (Kuhl FAST)0/3
~3 min; diagnostic accuracy ≈ full protocol.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| pre, fat-sat | Ax 3D | min | min | – | ≤1.5 | 320–360 | 384 | – | |
| 1st post, fat-sat | Ax 3D | min | min | – | ≤1.5 | 320–360 | 384 | Single post; subtraction + MIP | |
| optional | Ax | 3000 | 90 | – | 4 | 320–360 | 320 | ± DWI |
Kuhl FAST.45
Primary staging0/4
No routine DCE; spasmolytic optional.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Sag | 3000–4000 | 100 | – | 3 | 200–240 | 320 | Planning | ||
| high-res | Obl-Ax | 3000–4000 | 100 | – | 3 / 0 | 160–200 | 320–512 | ⟂ tumour; mrT, mrCRM, EMVI; <1 mm | |
| high-res | Obl-Cor | 3000 | 100 | – | 3 | 160–200 | 320 | Low tumours / anal canal | |
| Ax | long | min | – | 3–4 | 200–240 | 128 | b0/800–1000; nodes |
ESGAR/Radiology Assistant.47
Restaging (post-neoadjuvant)0/2
DWI integral to distinguishing residual tumour from fibrosis.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| high-res | Obl-Ax | 3000–4000 | 100 | – | 3 | 160–200 | 320–512 | Fibrosis vs tumour | |
| Ax | long | min | – | 3–4 | 200–240 | 128 | High b — residual tumour |
ESGAR Part II.47
MRCP (standard)0/4
Heavily T2W; static bile/pancreatic fluid bright.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Cor obl 3D | resp-trig | 500–700 | – | 1–1.5 iso | 300–360 | 320 | MIP / reformats | ||
| Cor radial | – | 800–1000 | – | 40–60 slab | 300 | 256 | Quick overview | ||
| Ax/Cor | – | 90 | – | 4–5 | 320–380 | 256 | Parenchyma, ducts | ||
| ± post-Gd | Ax 3D | min | min | – | 3 | 360 | 256 | If mass/inflammation |
ABC of MRCP.48
Secretin-enhanced MRCP0/2
IV secretin stimulates exocrine flow — duct dynamics / compliance.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| serial | Cor slab | – | 800–1000 | – | 40–50 slab | 300 | 256 | Serial ~10–15 min post-secretin | |
| Cor obl 3D | resp-trig | 600 | – | 1–1.5 iso | 320 | 320 | Baseline anatomy |
Secretin-MRCP.48
MR enterography (standard)0/5
~1–1.5 L oral contrast for distension + antiperistaltic agent.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Cor + Ax | – | 90 | – | 4–5 | 380–420 | 256 | ± fat-sat; distension | ||
| Cor + Ax | min | min | – | 4–5 | 380–420 | 256 | Wall, mesentery | ||
| Ax | long | min | – | 5 | 380–420 | 128 | b0/800; inflammation | ||
| motility | Cor | min | min | – | 8–10 | 400 | 192 | ~20 s/level | |
| dynamic post-Gd fat-sat | Ax 3D | min | min | – | 3 | 380–420 | 256 | Enteric-phase mural enhancement |
SAR consensus.49
Abbreviated (non-contrast)0/3
≤5 sequences, <12 min room time, no IV contrast.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Cor + Ax | – | 90 | – | 4–5 | 380–420 | 256 | ± fat-sat | ||
| Cor | min | min | – | 4–5 | 400 | 256 | Wall | ||
| Ax | long | min | – | 5 | 400 | 128 | b0/800 |
Abbreviated MRE.49
Adrenal mass (adenoma vs non-adenoma)0/4
Chemical-shift (in/opposed-phase) is the workhorse: intracellular-lipid signal drop-out on opposed-phase → lipid-rich adenoma (signal-intensity index >16.5%, or visual dropout vs spleen). Lipid-poor/indeterminate → dynamic post-Gd (or CT washout). DWI does not reliably separate adenoma from malignancy.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| chemical shift | Ax | min | in ~4.4 / opp ~2.2 | – | 4–5 | 320–400 | 256 | Adenoma drop-out; SI index >16.5% | |
| ± fat-sat | Ax/Cor | 1500–2500 | 90 | – | 4–5 | 320–400 | 256 | Cyst, phaeo (light-bulb), necrosis | |
| dynamic post-Gd, fat-sat | Ax 3D | min | min | – | 3 | 320–400 | 224 | Lipid-poor / indeterminate; phaeo, ACC, mets | |
| adjunct | Ax | long | min | – | 5 | 320–400 | 128 | b0/800; does not separate adenoma vs malignancy |
Solid renal mass (ccLS)ccLS0/4
Clear-cell Likelihood Score (ccLS 1–5) for indeterminate small (cT1) solid renal masses. Three core features: T2 signal of the enhancing tissue, corticomedullary-phase enhancement, and microscopic fat (in/opposed-phase drop-out); DWI and macroscopic fat are adjuncts. Subtraction confirms true enhancement.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Ax + Cor | 2000–4000 | 90 | – | 3–4 | 320–380 | 320 | Predominant T2 signal of enhancing tissue | ||
| chemical shift | Ax | min | dual-echo | – | 3–4 | 320–380 | 256 | Microscopic (intracellular) fat drop-out | |
| Ax | long | min | – | 4–5 | 320–380 | 128 | b0/800; adjunct feature; ADC | ||
| multiphase post-Gd, fat-sat | Ax/Cor 3D | min | min | – | 3 | 320–380 | 224 | Corticomedullary (key) / nephrographic / excretory; subtraction |
ccLS (Radiology, How We Do It).80
Bladder cancer (VI-RADS)VI-RADS0/3
VI-RADS (1–5) predicts detrusor (muscularis propria) invasion. Moderate bladder distension; image before biopsy/TURBT or ≥2 weeks after. T2 (structural) + DWI + DCE combine into the score; DWI is the dominant sequence.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| high-res, small-FOV | Ax + Sag + Cor | 3000–5000 | 100 | – | 3–4 | 200–250 | 320–384 | Muscularis propria integrity; VI-RADS structural | |
| dominant | Ax (± Sag) | long | min | – | 3–4 | 200–250 | 128 | b0/800–1000 + calc b1400–2000; stalk/interface | |
| DCE | Ax (± Sag) 3D | min | min | – | ≤3 | 220–260 | 224 | ~30 s temporal; early tumour vs muscle enhancement |
VI-RADS (Panebianco, Eur Urol 2018).81
Perianal fistula (St James)0/5
Small-FOV centred on the anal canal; plane axial- and coronal-oblique orthogonal/parallel to the canal. St James grade 1–5 (intersphincteric → trans-sphincteric → supralevator, ± abscess/secondary tracks) + active vs fibrotic (T2/STIR-bright + enhancement = active). No luminal contrast needed.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| high-res, small-FOV | Ax-obl + Cor-obl | 3000–4000 | 90 | – | 3 / 0 | 180–220 | 320 | Tract, internal opening, sphincter relation (St James) | |
| Ax-obl + Cor-obl | 3000–4000 | 90 | 150–180 | 3 | 180–220 | 320 | Active tract/abscess bright; secondary extensions | ||
| Ax-obl | 500–700 | 10 | – | 3–4 | 200–240 | 256 | Anatomy, ischioanal fat planes | ||
| Ax | long | min | – | 4 | 200–240 | 128 | b0/800; abscess restricts; adjunct to post-Gd | ||
| Ax-obl + Cor-obl | min | min | – | 3 | 180–220 | 256 | Active (enhancing) vs fibrotic; abscess wall |
MRI of perianal fistulas (RadioGraphics 2025).82
Endometrial cancer0/5
ESUR 2025, aligned to 2023 FIGO.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Sag | 3000–4000 | 100 | – | 3–4 | 200–240 | 320 | – | ||
| small-FOV, short-axis uterus | Obl | 3000 | 100 | – | 3–4 | 200–240 | 320 | Myometrial invasion | |
| Ax obl | long | min | – | 3–4 | 220–260 | 128 | b0/800–1000 | ||
| DCE | Sag 3D | min | min | – | 3 | 240 | 224 | Invasion depth (equilibrium) | |
| Ax | 500 | 10 | – | 5 | 320 | 256 | Nodes |
ESUR endometrial.50
Cervical cancer0/4
T2 + DWI for staging/response/recurrence; DCE optional.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Sag | 3000–4000 | 100 | – | 3–4 | 200–240 | 320 | – | ||
| small-FOV ⟂ cervix | Obl-Ax | 3000 | 100 | – | 3–4 | 180–220 | 320 | Parametrial invasion | |
| Ax obl | long | min | – | 3–4 | 220–260 | 128 | b0/800–1000 | ||
| DCE optional | Sag 3D | min | min | – | 3 | 240 | 224 | Research / recurrence |
ESUR cervical.51
Ovarian / adnexalO-RADS0/5
O-RADS MRI risk score from solid-tissue enhancement — DCE time-intensity curve (low / intermediate / high) vs the outer myometrium; a non-DCE pathway uses delayed post-contrast enhancement relative to myometrium.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| small-FOV | Sag + Ax + Cor | 3000–4000 | 100 | – | 3–4 | 200–240 | 320 | Solid tissue, locules, fat/fibrous | |
| Ax | 500–700 | 10 | – | 4–5 | 300–340 | 256 | Fat vs blood (pair with FS) | ||
| fat-sat | Ax | 500–700 | 10 | – | 4–5 | 300–340 | 256 | Endometrioma/haemorrhage vs fat | |
| Ax | long | min | – | 4–5 | 300–340 | 128 | b0/800–1000; solid components | ||
| DCE | Ax 3D | min | min | – | ≤3 | 240–300 | 224 | 15 s temporal, start 30 s pre-Gd, 4 min; TIC vs myometrium |
O-RADS MRI (ACR).69
Endometriosis (deep pelvic)0/4
ESUR 2025: fasting + antiperistaltic agent, moderate bladder filling, ± bowel / vaginal-rectal opacification; compartment-based reporting; T1 fat-sat is key to confirm haemorrhagic foci.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| high-res, multiplanar | Sag + Ax + Cor | 3000–4000 | 100 | – | 3–4 | 200–250 | 320–384 | DIE: uterosacrals, torus, pouch of Douglas, rectovaginal | |
| Ax | 500–700 | 10 | – | 4–5 | 300–340 | 256 | Baseline | ||
| fat-sat | Ax (± Sag) | 500–700 | 10 | – | 4–5 | 300–340 | 256 | Confirm blood products (T1-bright persists) | |
| cover kidneys | Cor | 3000 | 100 | – | 4–5 | 350–400 | 320 | Ureteric involvement / hydronephrosis |
ESUR endometriosis 2025.70
Fibroids / adenomyosis0/5
ESUR leiomyoma: pre-uterine-artery-embolisation map — fibroid number/size/FIGO location + enhancement (viability); report coexisting adenomyosis (junctional zone >12 mm; affects UAE outcome).
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Sag | 3000–4000 | 100 | – | 4 | 240–280 | 320 | Fibroid map (FIGO), junctional zone | ||
| Ax | 3000–4000 | 100 | – | 4 | 240–280 | 320 | Number, size, location | ||
| Ax | 500–700 | 10 | – | 5 | 300–340 | 256 | Haemorrhagic/red degeneration | ||
| Ax | long | min | – | 4–5 | 300 | 128 | b0/800; atypical/rapid-growth (sarcoma caution) | ||
| DCE / post-Gd | Sag + Ax 3D | min | min | – | 3 | 260–300 | 224 | Viability — pre-UAE (non-enhancing = poor target); ovarian supply |
ESUR leiomyoma.71
Placenta accreta spectrum0/3
Obstetric, usually 3rd trimester; NO gadolinium; moderate bladder filling. SAR–ESUR 7 MRI features: dark intraplacental T2 bands, placental bulge, myometrial thinning, bladder-wall interruption, focal exophytic mass, abnormal vascularity, heterogeneity.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| T2, heavily-weighted | Sag + Ax + Cor | – | 90 | – | 4 | 300–400 | 256 | No contrast; dark T2 bands, bulge, myometrial thinning | |
| Sag + Ax | min | min | – | 4 | 300–400 | 256 | Uterine/bladder interface, serosa | ||
| optional | Ax | long | min | – | 5 | 350–400 | 128 | Optional — placental boundary delineation |
SAR–ESUR PAS consensus.72
Appendicitis (non-contrast)0/5
US-first; MRI when ultrasound is inconclusive — the imaging of choice in pregnancy and often in children (no ionising radiation). 1.5 T preferred (limits fetal heating); no oral/IV contrast. Positive: dilated (>7 mm) blind-ending tubular structure, wall oedema, periappendiceal fluid/fat stranding, restricted diffusion.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Ax + Cor | – | 90 | – | 4–5 | 300–360 | 256 | Large-FOV survey; blind-ending tube | ||
| fat-sat / STIR | Ax + Cor | – | 90 | 150–180 | 4–5 | 300–360 | 256 | Periappendiceal fluid, fat stranding | |
| in/opposed-phase | Ax | min | dual-echo | – | 3–4 | 320–380 | 256 | Appendicolith, blood, fat planes (no Gd) | |
| Ax | long | min | – | 4–5 | 300–360 | 128 | b0/800; inflamed wall, abscess | ||
| optional | Cor | min | min | – | 4–5 | 320–380 | 256 | Motion-robust; free fluid, bowel |
ACR AC Right Lower Quadrant Pain 2022; MR appendicitis in pregnancy.73,74
Acute abdomen in pregnancy0/6
Non-contrast maternal survey for non-obstetric acute abdomen/pelvis — appendicitis, cholecystitis/choledocholithiasis, adnexal torsion, ovarian-vein thrombosis, urolithiasis/hydronephrosis, bowel obstruction. 1.5 T; multiplanar; add thick-slab MRCP if biliary.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Ax + Cor + Sag | – | 90 | – | 4–5 | 350–400 | 256 | Diaphragm→pubis survey; fluid/oedema | ||
| fat-sat / STIR | Ax + Cor | – | 90 | 150–180 | 4–5 | 350–400 | 256 | Inflammation, oedema | |
| in/opposed-phase | Ax | min | dual-echo | – | 3–4 | 350–400 | 256 | Blood, fat, adrenal; no Gd | |
| Ax | long | min | – | 5 | 350–400 | 128 | b0/800; abscess, torsion, bowel | ||
| Cor + Ax | min | min | – | 4–5 | 380–420 | 256 | Bowel, ovarian vein, free fluid | ||
| if biliary | Cor radial | – | 800–1000 | – | 40–60 slab | 300 | 256 | Choledocholithiasis / CBD |
MR acute abdomen in pregnancy (RadioGraphics).74
Fetal MRI (brain ± body)0/5
Complementary to neurosonography; 1.5 T standard (3 T acceptable — ACR–SPR: minimal fetal risk); NO contrast, NO maternal sedation. Single-shot T2 is the workhorse, re-planned to fetal anatomy for every stack; keep SAR in normal operating mode and minimise scan time.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| workhorse | 3 planes to fetal brain | – | 90–140 | – | 3–4 / 0 | small (fetal head) | 256 | Re-plan each stack; cortex, ventricles, posterior fossa | |
| 3 planes to fetal body | – | 90 | – | 3–4 | fetal trunk | 256 | Thorax/abdomen, lung signal, GI | ||
| Multiplanar | min | min | – | 3–4 | fetal | 256 | Heart/vessels, spine; motion-robust | ||
| Ax | min | min | – | 4–5 | fetal | 192 | Fat, meconium (bowel), haemorrhage, thyroid/liver | ||
| Ax | long | min | – | 4–5 | fetal | 128 | b0/600–700; brain injury (ADC), blood/mineral (EPI/T2*) |
- Free-breathing with respiratory navigators/triggering; motion-robust radial acquisitions; feed-and-wrap for infants.52
- DL / compressed-sensing acceleration; DL low-dose gadolinium reconstruction to cut contrast burden.
- Paediatric IBD MRE: non-contrast / abbreviated protocols + DWI to avoid repeated gadolinium.
- MRI is preferred over CT for non-obstetric acute abdomen/pelvis and may be performed in any trimester when clinically indicated — no proven harm at 1.5 T or 3 T.3
- Avoid gadolinium unless essential: GBCAs cross the placenta and have been associated with rare adverse fetal/childhood outcomes (stillbirth/neonatal death, inflammatory/infiltrative skin conditions).77
- No routine sedation or fasting (unless MRCP); left-lateral decubitus in the 3rd trimester to relieve IVC compression; keep SAR in normal operating mode and minimise acoustic noise and scan time.
Cardiac & vascular
Modular, indication-based (SCMR). Heart protocols are assembled per clinical question; mapping and iron thresholds need local reference ranges.
High-Yield Pearls — cardiac & vascular
- Modular SCMR protocols are assembled per clinical question; cine bSSFP is the functional backbone for volumes and wall motion.
- Ischaemia: vasodilator (adenosine) stress-first perfusion, then rest; LGE for viability/scar (TI ~300–420 ms, 10–20 min post-Gd; PSIR is less TI-sensitive).
- Tissue characterisation: native/post T1 & T2 mapping with ECV — always interpret against local reference ranges.
- Myocarditis (2018 Lake Louise): one T2-based plus one T1-based criterion.
- Iron (T2*): mid-septal short-axis ROI; >20 ms normal, <10 ms severe (10–20 ms mild–moderate).
- MRA: first-pass CE-MRA with bolus timing; QISS or ferumoxytol for non-contrast MRA when GBCA is contraindicated.
Function / ischaemia0/3
Stress first, then ≥10 min before rest; add LGE for viability.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| SA stack + 2/3/4-ch | ~3 | ~1.4 | – | 6–8 / 2 | 340–380 | ~1.8 mm | Function/volumes; ~35–50 ms/phase | ||
| vasodilator stress | 3 × SA | ~2 | ~1 | sat-recovery | 8–10 | 340 | 128 | Adenosine; ~0.05–0.075 mmol/kg first-pass | |
| SA + LAX | R-R | ~3 | 300–420 | 6–8 | 340 | 192 | 10–20 min post-Gd; PSIR less TI-sensitive |
SCMR protocols; cine/LGE params; 2025 perfusion consensus.53,54,58
Cardiomyopathy0/4
Native T1 ~950–1050 ms (1.5T) / ~1150–1200 ms (3T) — use local normals.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| SA + LAX | ~3 | ~1.4 | – | 6–8 | 340–380 | ~1.8 mm | Function, wall thickness | ||
| native + post | SA basal/mid/apical | MOLLI | ~1 | scheme | 8 | 340 | 160 | ECV with haematocrit | |
| SA | – | multi | – | 8 | 340 | 160 | Oedema | ||
| SA + LAX | R-R | ~3 | 300–420 | 6–8 | 340 | 192 | Mid-wall/patchy = non-ischaemic |
Myocarditis0/4
Updated (2018) Lake Louise: one T2-based + one T1-based criterion.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| SA + LAX | ~3 | ~1.4 | – | 6–8 | 340 | ~1.8 mm | Function, pericardium | ||
| SA | – | multi | – | 8 | 340 | 160 | Oedema (T2 criterion) | ||
| native + post / ECV | SA | MOLLI | ~1 | scheme | 8 | 340 | 160 | T1 criterion | |
| SA + LAX | R-R | ~3 | 300–420 | 6–8 | 340 | 192 | Non-ischaemic pattern |
Lake Louise 2018.57
Iron overload (T2*)0/3
Cardiac T2* is the gold standard for myocardial iron.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| septal ROI | Mid-SA | – | multi (2–18 ms) | – | 8–10 | 340 | 160 | R2*=1000/T2*; >20 ms normal, <10 severe | |
| SA + LAX | ~3 | ~1.4 | – | 6–8 | 340 | ~1.8 mm | Function | ||
| liver | Ax (liver) | – | multi | – | 10 | 380 | 160 | LIC calibration (method-dependent) |
T2* thresholds.63
CE-MRA0/3
General-purpose default; carotid, aorta, peripheral runoff.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Cor 3D | min | min | – | 1–1.5 | per station | ~1 mm | First-pass Gd; test bolus / bolus tracking | ||
| time-resolved | Cor 3D | min | min | – | 1.5–2 | per station | ~1.5 mm | Dynamic (TWIST/TRICKS/4D-TRAK) | |
| optional supplement | Ax 3D | 20–25 | 3–7 | – | 0.6–1 | 200 | 320 | Carotid / intracranial |
Non-contrast MRA0/3
When gadolinium is contraindicated. Ferumoxytol steady-state (off-label) for infants/small vessels.
| ✓ | Sequence | Plane | TR | TE | TI | Slice/gap | FOV | Matrix/res | Other |
|---|---|---|---|---|---|---|---|---|---|
| Ax/Cor ECG-gated | R-R | min | quiescent | 2–3 | per station | ~1 mm | Peripheral runoff; renal-safe | ||
| Ax 3D | 20–25 | 3–7 | – | 0.6–1 | 200 | 320 | Carotid / intracranial | ||
| navigator, TSLIP | Cor | min | min | inversion | 1.5–2 | 300 | ~1.3 mm | Renal / aorta |
- Free-breathing, navigator & DL-accelerated cine replace multiple breath-holds; validated in children (2025–2026).64
- Ferumoxytol for CE-MRA / 4D flow in infants and small-caliber low-flow vessels, outperforming gadolinium under anesthesia.65
- 4D flow suits complex CHD anatomy; use pediatric resolution (2–2.5 mm³).59
MRI Patient Positioning — Quick Reference
Positioning, coil selection, centring landmarks, breathing strategy and comfort/immobilisation for common MRI exams, grouped by region. Expand a region to see the exam cards. Local protocols and coil availability vary — always follow your department’s SOP and manufacturer guidance.
Neuro7 exams
Brain (routine)
- Position
- Supine, head-first, arms by sides.
- Coil
- Head / head-neck array.
- Landmark / centring
- Centre on nasion (glabella); align canthomeatal line.
- Breathing
- n/a (still).
- Immobilisation / comfort
- Head cushions, forehead strap, ear plugs + defenders.
- Tips / common errors
- Keep head straight — rotation skews symmetric structures; pad to reduce motion.
Brain — epilepsy / hippocampal
- Position
- Supine, head-first, arms by sides.
- Coil
- Head / head-neck array.
- Landmark / centring
- Centre on nasion; angle obliques perpendicular to long axis of hippocampus.
- Breathing
- n/a.
- Immobilisation / comfort
- Head cushions, strap, hearing protection.
- Tips / common errors
- Prescribe thin coronal obliques ⟂ hippocampus; minimise head tilt for symmetry.
IAMs / CP angle
- Position
- Supine, head-first, arms by sides.
- Coil
- Head / head-neck array.
- Landmark / centring
- Centre on nasion; thin axial + high-res T2 through IACs.
- Breathing
- n/a.
- Immobilisation / comfort
- Head cushions, strap, ear protection.
- Tips / common errors
- Small FOV thin slices through IACs; symmetry critical for VII/VIII.
Pituitary / sella
- Position
- Supine, head-first, arms by sides.
- Coil
- Head array.
- Landmark / centring
- Centre on nasion; small-FOV coronal + sagittal through sella.
- Breathing
- n/a; dynamic post-contrast timing if microadenoma.
- Immobilisation / comfort
- Head cushions, strap, ear protection.
- Tips / common errors
- Thin (2–3 mm) coronal dynamic; time contrast for microadenoma.
Orbits
- Position
- Supine, head-first, eyes closed, gaze fixed straight ahead.
- Coil
- Head array (small surface coil optional).
- Landmark / centring
- Centre on orbits; fat-sat T2/T1 small FOV.
- Breathing
- n/a — instruct patient to keep eyes still.
- Immobilisation / comfort
- Head cushions, strap, ear protection.
- Tips / common errors
- Eyes still reduces motion blur; use fat suppression for orbital fat.
MRA — Circle of Willis
- Position
- Supine, head-first, arms by sides.
- Coil
- Head / head-neck array.
- Landmark / centring
- Centre on nasion; 3D TOF slab over circle of Willis.
- Breathing
- n/a.
- Immobilisation / comfort
- Head cushions, strap, ear protection.
- Tips / common errors
- Position slab low enough to capture terminal ICA/vertebrobasilar; no contrast for TOF.
Carotid MRA (neck)
- Position
- Supine, head-first, chin slightly extended, arms by sides.
- Coil
- Head-neck / neck array.
- Landmark / centring
- Centre on thyroid cartilage; coronal CE-MRA aortic arch → circle of Willis.
- Breathing
- Suspend breathing briefly for arch acquisition.
- Immobilisation / comfort
- Neck support, strap, ear protection.
- Tips / common errors
- Time the contrast bolus for arterial phase; cover arch to intracranial ICA.
Spine4 exams
Cervical spine
- Position
- Supine, head-first, arms by sides, shoulders down.
- Coil
- Head-neck + spine array.
- Landmark / centring
- Centre on thyroid cartilage (~C4).
- Breathing
- n/a; quiet breathing.
- Immobilisation / comfort
- Neck cushion, knee bolster, strap, ear protection.
- Tips / common errors
- Pull shoulders down to reduce brachial-plexus wrap; saturate swallowing motion.
Thoracic spine
- Position
- Supine, head-first, arms by sides.
- Coil
- Spine array (± body array).
- Landmark / centring
- Centre at mid-sternum (~T6); count from C7 or L5 to level.
- Breathing
- Quiet breathing.
- Immobilisation / comfort
- Knee bolster, strap, ear protection.
- Tips / common errors
- Use a vitamin-E/skin marker or count vertebrae to confirm level.
Lumbar spine
- Position
- Supine, head-first, knees flexed over bolster.
- Coil
- Spine array.
- Landmark / centring
- Centre on iliac crest (~L4).
- Breathing
- Quiet breathing.
- Immobilisation / comfort
- Large knee bolster (flattens lordosis), strap, ear protection.
- Tips / common errors
- Knee bolster reduces lordosis & back pain; sagittal to count levels.
Whole spine
- Position
- Supine, head-first, arms by sides.
- Coil
- Head-neck + full spine array (multi-station).
- Landmark / centring
- Centre first station at orbit; step-table sagittal C-to-sacrum.
- Breathing
- Quiet breathing.
- Immobilisation / comfort
- Neck + knee support, strap, ear protection.
- Tips / common errors
- Composed multi-station sagittal; keep spine straight for stitching.
MSK10 exams
Shoulder
- Position
- Supine, head-first, affected arm at side, hand supinated (palm up), slight external rotation.
- Coil
- Dedicated shoulder / flexible surface coil.
- Landmark / centring
- Centre on humeral head / coracoid; small FOV.
- Breathing
- n/a.
- Immobilisation / comfort
- Sandbag/strap on hand to hold external rotation, ear protection.
- Tips / common errors
- External rotation opens the joint; feet-first if narrow shoulders/claustrophobia.
Elbow
- Position
- Prone, arm extended overhead “superman” (or supine at side), thumb up.
- Coil
- Extremity / flexible surface coil.
- Landmark / centring
- Centre on olecranon / joint line.
- Breathing
- n/a.
- Immobilisation / comfort
- Foam pads around elbow, strap, ear protection.
- Tips / common errors
- Superman position centres elbow in bore; at-side alternative for large/older patients.
Wrist
- Position
- Prone, arm overhead “superman”, wrist pronated, or at side.
- Coil
- Wrist / small extremity coil.
- Landmark / centring
- Centre on radiocarpal joint.
- Breathing
- n/a.
- Immobilisation / comfort
- Foam pads, strap, ear protection.
- Tips / common errors
- Keep wrist in coil isocentre; superman reduces off-centre artefact.
Hand / fingers
- Position
- Prone, arm overhead “superman”, palm down on coil.
- Coil
- Small flexible / extremity coil.
- Landmark / centring
- Centre on metacarpals / affected digit.
- Breathing
- n/a.
- Immobilisation / comfort
- Pads to immobilise fingers, strap, ear protection.
- Tips / common errors
- Immobilise digit; place ROI at isocentre for small FOV/high resolution.
Hip (single)
- Position
- Supine, feet-first, legs straight, feet gently internally rotated & taped.
- Coil
- Body / flexible array over hip.
- Landmark / centring
- Centre on femoral head (~2 cm below ASIS line).
- Breathing
- Quiet breathing.
- Immobilisation / comfort
- Foot tape for internal rotation, knee support, ear protection.
- Tips / common errors
- Internal rotation of foot elongates femoral neck; contralateral hip for AVN compare.
Pelvis / SIJ
- Position
- Supine, feet-first, legs straight.
- Coil
- Body + spine array.
- Landmark / centring
- Centre midway between ASIS and pubic symphysis; oblique coronals along sacrum for SIJ.
- Breathing
- Quiet breathing.
- Immobilisation / comfort
- Knee support, strap, ear protection.
- Tips / common errors
- For SIJ prescribe semi-coronal oblique parallel to sacrum; fat-sat for oedema.
Knee
- Position
- Supine, feet-first, knee slightly flexed (~10–15°) & externally rotated ~15°.
- Coil
- Dedicated knee (HD) coil.
- Landmark / centring
- Centre on inferior pole of patella / joint line.
- Breathing
- n/a.
- Immobilisation / comfort
- Knee coil, foam wedge, strap, ear protection.
- Tips / common errors
- Slight external rotation aligns ACL for sagittal obliques; feet-first eases claustrophobia.
Ankle
- Position
- Supine, feet-first, ankle in neutral 90° dorsiflexion.
- Coil
- Ankle / foot (extremity) coil.
- Landmark / centring
- Centre on medial malleolus / tibiotalar joint.
- Breathing
- n/a.
- Immobilisation / comfort
- Coil + pads to hold 90°, strap, ear protection.
- Tips / common errors
- Neutral 90° avoids magic-angle on tendons; feet-first minimises bore travel.
Foot
- Position
- Supine, feet-first, foot in coil, toes up (or plantar per pathology).
- Coil
- Foot / extremity coil.
- Landmark / centring
- Centre on midfoot / affected region.
- Breathing
- n/a.
- Immobilisation / comfort
- Pads to immobilise, strap, ear protection.
- Tips / common errors
- Angle short-axis to metatarsals for forefoot; small FOV high resolution.
TMJ
- Position
- Supine, head-first, bite blocks for open/closed mouth series.
- Coil
- Bilateral small surface (TMJ) coils or head coil.
- Landmark / centring
- Centre on condyles; thin oblique sagittal ⟂ condylar axis.
- Breathing
- n/a.
- Immobilisation / comfort
- TMJ coils, bite block, head strap, ear protection.
- Tips / common errors
- Acquire closed then open (bite block) to assess disc position/reduction.
Body9 exams
Liver / MRCP
- Position
- Supine, head-first (or feet-first), arms above head.
- Coil
- Body array + spine array.
- Landmark / centring
- Centre on xiphisternum.
- Breathing
- Breath-hold in expiration; MRCP thick-slab often respiratory-triggered.
- Immobilisation / comfort
- Arms up on pads, strap, ear protection; belt for navigator.
- Tips / common errors
- Consistent expiration breath-holds; fast on secretin/fatty-meal per protocol.
Pancreas
- Position
- Supine, head-first, arms above head.
- Coil
- Body + spine array.
- Landmark / centring
- Centre on xiphisternum / L1 level.
- Breathing
- Breath-hold expiration; dynamic post-contrast phases.
- Immobilisation / comfort
- Arms up, strap, ear protection.
- Tips / common errors
- Thin axial dynamic for lesion conspicuity; consistent breath-hold timing.
Adrenals
- Position
- Supine, head-first, arms above head.
- Coil
- Body + spine array.
- Landmark / centring
- Centre on xiphisternum / upper abdomen.
- Breathing
- Breath-hold expiration.
- Immobilisation / comfort
- Arms up, strap, ear protection.
- Tips / common errors
- In/opposed-phase chemical shift for adenoma signal drop.
Kidneys / MR urography
- Position
- Supine, head-first, arms above head.
- Coil
- Body + spine array.
- Landmark / centring
- Centre midway xiphisternum–umbilicus.
- Breathing
- Breath-hold; heavily-T2 urography may be respiratory-triggered.
- Immobilisation / comfort
- Arms up, strap, ear protection; hydration ± furosemide per protocol.
- Tips / common errors
- Coronal thick-slab T2 urography; dynamic excretory phase for collecting system.
Small bowel — MR enterography
- Position
- Supine or prone, head-first, arms above head; oral contrast pre-filled.
- Coil
- Body + spine array.
- Landmark / centring
- Centre on umbilicus.
- Breathing
- Breath-hold + free-breathing cine of loops; antiperistaltic agent given.
- Immobilisation / comfort
- Arms up, strap, ear protection.
- Tips / common errors
- Ensure adequate luminal distension (oral prep); prone can spread loops.
Rectum
- Position
- Supine, head-first, arms across chest or up; empty rectum ± gel.
- Coil
- Body / pelvic array (small FOV).
- Landmark / centring
- Centre on symphysis pubis; obliques ⟂ tumour axis.
- Breathing
- Quiet breathing; antiperistaltic agent.
- Immobilisation / comfort
- Knee support, strap, ear protection.
- Tips / common errors
- High-res T2 obliques ⟂ tumour long axis; no fat-sat for staging.
Prostate
- Position
- Supine, head-first, arms across chest.
- Coil
- Pelvic phased-array (endorectal rarely).
- Landmark / centring
- Centre on symphysis pubis.
- Breathing
- Quiet breathing; antiperistaltic agent to reduce rectal motion.
- Immobilisation / comfort
- Knee support, strap, ear protection.
- Tips / common errors
- Antispasmodic + empty rectum reduce motion/susceptibility on DWI.
Female pelvis
- Position
- Supine, head-first, arms across chest.
- Coil
- Pelvic phased-array (body + spine).
- Landmark / centring
- Centre on symphysis pubis; obliques along uterine/cervical axis.
- Breathing
- Quiet breathing; antiperistaltic agent.
- Immobilisation / comfort
- Knee support, strap, ear protection.
- Tips / common errors
- Align obliques to uterine axis (endometrium) or cervical canal per indication.
Breast
- Position
- Prone, head-first, both breasts pendant in coil apertures, arms up.
- Coil
- Dedicated breast coil (bilateral).
- Landmark / centring
- Centre on nipple line / mid-breast.
- Breathing
- Free-breathing; dynamic contrast subtraction.
- Immobilisation / comfort
- Prone breast coil, pads, strap, ear protection.
- Tips / common errors
- Ensure breasts fully pendant with no skin folds; symmetric positioning for subtraction.
Cardiac / vascular3 exams
Cardiac — function / viability
- Position
- Supine, head-first, arms above head; ECG leads placed.
- Coil
- Cardiac phased-array + ECG gating.
- Landmark / centring
- Centre on mid-sternum / left chest.
- Breathing
- Repeated breath-holds in expiration; ECG-gated cine.
- Immobilisation / comfort
- ECG electrodes, arms up, strap, ear protection.
- Tips / common errors
- Good ECG trace essential; consistent end-expiration breath-holds for slice registration.
Aorta MRA
- Position
- Supine, head-first, arms above head; ECG for root.
- Coil
- Body + spine array (± ECG).
- Landmark / centring
- Centre over region (arch/thoracic/abdominal).
- Breathing
- Breath-hold for thoracic; timed CE-MRA bolus.
- Immobilisation / comfort
- Arms up, strap, ear protection.
- Tips / common errors
- Time contrast to arterial phase; ECG-gate root for aortic-valve/dissection flap.
Peripheral run-off MRA
- Position
- Supine, feet-first, legs straight & together, feet padded.
- Coil
- Peripheral vascular array + body/spine (multi-station).
- Landmark / centring
- Centre first station at renal arteries; bolus-chase to feet.
- Breathing
- Suspend breathing for abdominal station.
- Immobilisation / comfort
- Legs strapped together, foot pads, ear protection.
- Tips / common errors
- Bolus-chase timing critical to avoid venous contamination distally.
Head & neck / other3 exams
Neck (soft tissue)
- Position
- Supine, head-first, arms by sides, shoulders down, neutral neck.
- Coil
- Head-neck / neck array.
- Landmark / centring
- Centre on thyroid cartilage / hyoid.
- Breathing
- Quiet breathing; suspend swallowing during acquisition.
- Immobilisation / comfort
- Neck support, strap, ear protection.
- Tips / common errors
- Ask patient not to swallow during scans; saturate to reduce swallowing motion.
Brachial plexus
- Position
- Supine, head-first, arms by sides, shoulders relaxed and down.
- Coil
- Head-neck + spine array.
- Landmark / centring
- Centre on lower neck (~C7/T1).
- Breathing
- Quiet breathing.
- Immobilisation / comfort
- Neck & shoulder support, strap, ear protection.
- Tips / common errors
- Coronal/oblique STIR along plexus; drop shoulders to include roots to cords.
Fetal MRI
- Position
- Supine (or left-lateral decubitus if supine hypotension), feet-first, arms up or by sides.
- Coil
- Body + spine array over gravid uterus.
- Landmark / centring
- Centre over uterus per gestation (fundal height).
- Breathing
- Free-breathing SSFSE single-shot (motion-robust); no breath-hold.
- Immobilisation / comfort
- Wedge under right hip if needed, strap, ear protection; reassure re: safety.
- Tips / common errors
- Use fast single-shot to freeze fetal motion; left-tilt avoids aortocaval compression.
Feet-first entry (knee, ankle, foot, lower-limb vascular, pelvis, hip) reduces bore travel and helps claustrophobic patients. Breath-holds are performed in expiration for consistent diaphragm position. Hearing protection is mandatory for every patient.
Phase-encode direction & saturation bands
Two levers that decide where artefacts land — not whether they exist. Ghosting from motion, pulsation and aliasing (wrap) is always mapped along the phase-encode (PE) axis; you rotate that axis, and drop saturation bands, to push those ghosts off the anatomy you care about. Conventions below are widely taught but vendor- and site-dependent — reason from the artefact source, don’t memorise blindly.
- Move motion/pulsation ghosts off the ROI. Ghosts propagate along PE. Put PE perpendicular to the line joining the pulsatile/moving source and the target (e.g. swap so vessel ghosts run head–foot along the spine, not across the cord).
- Shorten the scan. Scan time = TR × phase steps × averages. Put the shorter anatomical dimension in phase and cut phase FOV (rectangular FOV) → fewer phase steps → faster. Frequency direction is “free.”
- Avoid wrap (aliasing). Orient PE along the dimension that fits the FOV, or add phase oversampling / a sat band over the wrapping tissue.
Neuro
| Exam / sequence | PE direction | Why | Example / swap |
|---|---|---|---|
| Axial brain T2 / FLAIR / T1 | R ↔ L | L–R is the shorter dimension → rectangular FOV shortens scan; throws CSF & vascular pulsation ghosts side-to-side, away from brainstem & midline. | Swap to A–P if L–R wrap from broad shoulders/positioning. |
| Sagittal brain | S ↔ I (head–foot) | Keeps A–P vascular/CSF pulsation ghosts out of the sagittal display; foot–head fits the long axis. | A–P acceptable with flow comp. |
| Orbits (axial/coronal) | R ↔ L | Eye-motion ghosting travels with globe movement (up–down); PE R–L keeps that ghost off the globe & optic nerve. | Add flow comp + thin slices; ask patient to fixate gaze. |
| IAM / posterior fossa (axial) | R ↔ L | Displaces transverse sinus & basilar pulsation ghosts laterally, off the IACs / CP angle. | Flow comp on T2. |
| MRA / TOF | R ↔ L (axial slab) | Minimises pulsation ghost across the circle of Willis; combine with flow comp and a superior/inferior travelling sat for arterial vs venous selectivity. | Venous TOF → sat inferiorly; arterial → sat superiorly. |
Axial-brain PE choice varies by vendor default (some ship A–P). The reasoning — shorter dimension + pulsation displacement — is what to teach.
Spine
| Exam / sequence | PE direction | Why | Sat band |
|---|---|---|---|
| Sagittal C-spine | S ↔ I (head–foot) | Swallowing, pharyngeal motion and carotid pulsation are anterior; if PE were A–P their ghosts would project straight onto the cord. PE S–I runs those ghosts vertically instead. | Anterior sat over pharynx / great vessels. |
| Sagittal T- / L-spine | S ↔ I (head–foot) | Aortic/IVC pulsation and bowel/respiratory motion are anterior — same logic, keep their ghosts off the canal & cord/conus. | Anterior sat over aorta / bowel. |
| Axial C-spine | A ↔ P | Shorter neck dimension; combine with anterior sat to knock down swallowing ghost. | Anterior sat. |
| Axial L-spine | A ↔ P | Fits the FOV; anterior sat suppresses aortic pulsation projecting posteriorly onto discs/canal. | Anterior sat over aorta. |
Body & pelvis
| Exam / sequence | PE direction | Why | Sat / technique |
|---|---|---|---|
| Axial abdomen (liver, T2/T1) | A ↔ P | A–P is shorter → rectangular FOV; but respiratory ghost also runs A–P onto kidneys/liver — so pair with breath-hold or navigator, not just PE choice. | Breath-hold / respiratory triggering; anterior sat over subcut fat. |
| Axial abdomen with arm-down wrap | swap to R ↔ L or oversample | Arms in the FOV wrap along phase; oversample or move PE to the non-wrapping axis. | Phase oversampling / lateral sat. |
| Coronal abdomen/pelvis | R ↔ L | Shorter dimension coronally; keeps aortic pulsation ghost lateral. | Superior/inferior sat to cut in-flow artefact. |
| Prostate / rectum (axial T2) | R ↔ L | Displaces rectal-gas susceptibility & iliac vessel pulsation laterally, off the peripheral zone. | Anti-peristaltic (hyoscine/glucagon). |
| MRCP (coronal HASTE/3D) | R ↔ L | Keeps A–P respiratory/duodenal motion ghosts off the biliary tree. | Respiratory triggering + oral negative contrast. |
Cardiac & vascular
| Exam / sequence | PE direction | Why | Sat / technique |
|---|---|---|---|
| Cardiac cine / black-blood | A ↔ P (with fold suppression) | Chest wall & cardiac motion; PE choice + ECG gating keep ghosts off the myocardium. | Inferior/anterior sat to null in-flowing blood (black-blood double IR); ECG gating. |
| Contrast MRA | along shortest FOV dimension | Minimise phase steps for speed within the arterial bolus window. | No sat (want vessel signal); centric k-space ordering. |
MSK
| Exam / sequence | PE direction | Why | Swap / sat |
|---|---|---|---|
| Axial knee | R ↔ L | Popliteal artery is posterior & midline; PE R–L runs its pulsation ghost side-to-side, off the patellofemoral joint & menisci. | Add sat over popliteal vessels if ghost persists. |
| Sagittal / coronal knee | S ↔ I | Keeps popliteal pulsation ghost running head–foot, not across cruciates/menisci. | Flow comp on PD/T2. |
| Axial shoulder | A ↔ P | Axillary vessel pulsation runs off the glenoid/labrum; A–P fits the FOV. | Swap or sat if brachial pulsation crosses labrum. |
| Ankle / foot | S ↔ I or A ↔ P | Posterior tibial vessel pulsation; orient PE to keep ghost off the tibiotalar joint/tendons. | Anterior/posterior sat as needed. |
| Long-axis limbs / run-off | along limb axis | Fewer phase steps over the long, narrow FOV; keeps vessel ghosts running with the limb. | Travelling sat for run-off. |
Saturation bands — types & placement
- Spatial pre-sat A slab that tips & spoils signal from tissue before readout. Place it perpendicular to the flow/motion and between the source and the ROI — never overlapping the ROI. Uses: anterior sat (spine — swallowing, aortic/carotid pulsation, respiration); superior/inferior sat (null in-flowing arterial or venous blood; black-blood cardiac; venous vs arterial MRA selectivity); lateral sat (arm/fold suppression).
- Travelling / tracking sat Moves with the slice through the volume — keeps flow suppression consistent across a stack (run-off MRA, TOF).
- Chemical (fat) sat Frequency-selective, not spatial — nulls fat everywhere in the FOV (SPAIR/fat-sat). Distinct from spatial sat; combine both when needed.
- Cost: each spatial sat pulse adds RF (SAR) and can reduce slices per TR; use the minimum that clears the artefact.
Reference values represent typical practice; always tailor to scanner, coil and patient. Educational content, not a substitute for your department’s validated protocols.
PACS: definitions, what to send & reformats
Getting the right images to the right place is part of the exam, not an afterthought. Below: what the archive tiers actually mean, the minimum series a radiologist expects for each body part, and the reformats (MPRs/MIPs) the radiographer is expected to reconstruct and push — before the patient leaves.
Core PACS terminology
- PACS
- Picture Archiving & Communication System — stores, retrieves, distributes and displays medical images. Talks to modalities and the RIS/EHR via DICOM and HL7.
- Primary archive
- The authoritative, long-term store of record — the “source of truth” the site is medico-legally required to retain for the full retention period. High-integrity, backed up, usually on-site or primary cloud.
- Secondary archive
- A second independent copy for redundancy / disaster recovery / business continuity — geographically or logically separate from primary, so loss of one site doesn’t lose the study. May be lower-cost/slower (“nearline”) storage.
- VNA
- Vendor-Neutral Archive — a storage layer independent of any single PACS vendor, holding images in standard DICOM so multiple PACS/EHR viewers can access one shared copy. Often serves as the primary archive across departments.
- On / near / off-line
- Tiered storage by access speed: on-line = instant (recent studies, fast disk); near-line = seconds–minutes (older studies, slower/cheaper media); off-line = manual retrieval (archive/tape).
- DICOM node / AE title
- A network destination on the DICOM network. Each device has an Application Entity (AE) title, IP and port — you “send to” a node by its AE title.
- C-STORE / query-retrieve
- DICOM services: C-STORE pushes images to a node; C-FIND / C-MOVE (query-retrieve) pulls studies from an archive.
- Worklist (MWL)
- Modality Worklist — the scanner pulls booked patient/exam demographics from the RIS so IDs and accession numbers match automatically (avoids typos & mismatched studies).
- Accession number
- Unique per-exam identifier from the RIS that ties images ↔ order ↔ report. Wrong accession = study lands on the wrong order.
- Series vs study
- A study is the whole exam for one accession; a series is one acquisition/sequence within it.
- Presentation state (GSPS)
- Saved annotations, measurements, window/level and reformat orientation stored alongside images so the reader sees what you set up.
- Key images / KOS
- Key Object Selection — flagged representative images (e.g. the measured lesion) so the reader/clinician finds the finding fast.
- Thin vs thick
- Thin-slice source data feeds reformats & 3D; thick/averaged series are for quick reading. Archive both when the protocol needs post-processing later.
What to send & which reformats to build — by body part
| Body part | Series to send | Reformats / reconstructions to make & send |
|---|---|---|
| Brain (routine) | All acquired: T1, T2, FLAIR, DWI + ADC map, T2* / SWI, post-Gd T1 (if given). | SWI minIP (thick) for microbleeds/veins; 3D T1 post-Gd → ax/cor/sag MPR; ensure ADC map is generated & sent (not just DWI). |
| Brain — epilepsy/tumour (3D) | 3D FLAIR, 3D T1 (pre/post), DWI+ADC. | Thin-slice 3D → orthogonal MPRs; hippocampal oblique-coronal reformats perpendicular to long axis of hippocampus. |
| MRA — intracranial / carotid TOF | Source axial images + acquired. | MIP: full-volume + targeted/rotational MIPs (per-vessel), plus keep source images (MIP can hide small aneurysms). |
| Pituitary / IAM | Thin coronal & sagittal T1/T2 ± dynamic post-Gd. | Small-FOV MPRs if 3D acquired; send dynamic phases in order. |
| Cervical / lumbar spine | Sag T1, Sag T2 (± STIR), Axial T2 (± T1) through relevant levels. | Axial obliques angled to each disc space for stenosis; if 3D, cor/sag reformats. Confirm level labelling. |
| MRCP | Thin-slab 3D + thick-slab radial HASTE, axial/coronal T2. | Rotational MIP / radial reprojections of the biliary tree from the 3D volume; send the radial set. |
| Liver / abdomen (dynamic) | In/out-phase, T2, DWI+ADC, dynamic post-Gd (pre, arterial, portal, delayed / hepatobiliary). | Subtraction (post − pre) for enhancement; label dynamic phases; ADC map; coronal reformat if 3D. |
| Prostate (mpMRI) | T2 (ax/cor/sag), DWI high-b + ADC, DCE dynamic. | Calculated high-b (e.g. b1400) if not acquired; ADC map; ensure DCE series ordered/labelled; PI-RADS key images. |
| Pelvis — gynae / rectal | T2 (ax/sag/cor), oblique T2 to organ axis, DWI+ADC, ± post-Gd. | Oblique reformats/acquisitions perpendicular & parallel to organ axis (short-axis to cervix/rectal wall); ADC map. |
| Cardiac MR | Cines (SA stack, 2/3/4-ch), T1/T2 mapping, LGE, perfusion. | Reformat short-axis stack from long-axis planning; map images (native/post-contrast T1, ECV if computed); send mapping colour overlays + source. |
| MSK — knee/shoulder/ankle | All planes PD/T2 fat-sat + T1; cartilage/effusion sequences. | If 3D isotropic → orthogonal & oblique MPRs (along ligament/labrum); radial reformats for hip labrum/shoulder. |
| MSK — 3D isotropic / tumour | Isotropic source + standard planes. | Orthogonal MPRs; long-axis + short-axis to the lesion/bone; whole-lesion measurement key images. |
| Peripheral / contrast MRA run-off | Source stations, mask & post-contrast. | Subtracted MIPs per station + composed whole-leg MIP; keep source for stenosis grading. |
Retention periods, archive architecture (VNA/primary/secondary) and required reformats vary by jurisdiction and department — follow your local imaging IT and reporting-radiologist standards. Educational content only.